Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Axovant's phase 3 study of RVT-101
.
Show all posts
Showing posts with label
Axovant's phase 3 study of RVT-101
.
Show all posts
Wednesday, November 18, 2015
First patients screened in Axovant's phase 3 study of RVT-101
›
Axovant Sciences Ltd. (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, recentl...
›
Home
View web version
